Found: 1
Select item for more details and to access through your institution.
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 3, p. 410, doi. 10.1038/bmt.2013.199
- By:
- Publication type:
- Article